Executive Assistant to CEO (m/f/d)

Assistant position providing administrative support to CEO and the whole organization. Acts as a first point of contact with the CEO’s office for individuals inside and outside of the organization.

Main tasks and responsibilities:

  • Supports the executive management in all administrative and organizational tasks
  • Drafts management presentations, reports and meeting minutes
  • Plans, organizes, and schedules own workload so that all activities are completed accurately and on time
  • Office management & data room management
  • Coordinates calendars and travel of executive team
  • Supports contract and insurance management
  • Supports Intellectual Property management
  • Creates and maintains content of corporate webpage
  • Coordinates and organizes internal and external company events
  • Supports HR activities, time tracking and payroll
  • Supports investor relations
  • Contact point for various internal and external partners


  • 6 – 10 years job experience as Executive Assistant
  • Bachelor’s degree or equivalent, alternatively a further training as Executive Assistant
  • Highly proficient on the full Microsoft office suite
  • Experienced in handling meeting programs/applications (MS Teams, Zoom)
  • Fluent in English and German, French is a plus


  • Excellent secretarial skills & ability to exercise sound judgment / Proactive, efficient and accurate management of demanding workload
  • Ability to work under time pressure and deadlines
  • Ability to work independently with professional discretion
  • Strong organizational and communication skills
  • Flexible, open-minded, and multitasking
  • Precise and accurate
  • Assertiveness, proactivity, professionalism, and confidence
  • Exceptional team player
  • Used to work in a multilingual environment
  • Affinity to the pharmaceutical industry

BioVersys is offering a great job opportunity for an Executive Assistant at 80%-100%. The start date is November 1st, 2021.

Applicant should send a CV and a cover letter including contact information of two references to Alina Lundin, All applicants must be legally authorized to work in Switzerland

The Company

BioVersys AG is a privately owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in Anti-Microbial Resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields. By this means BioVersys addresses the high unmet medical need for new treatments against life threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. The company’s most advanced R&D programs are in preclinical development for nosocomial infections (hospital infections) and Tuberculosis in collaboration with GlaxoSmithKline (GSK) and a consortium of the University of Lille. In 2020 BioVersys launched its first Phase I clinical trials.

BioVersys is a dynamic small pharmaceutical company with a highly innovative and diverse pipeline of novel antibacterial programs under development. Internationally regarded as one of the leading companies in antibiotic drug discovery and development, the company has received financial support in the form of several large non-dilutive funds e.g. from the European Innovative Medicines Initiative and CARB-X.